HomeSide effectsPancreatitis

Side-effect deep dive

Pancreatitis claim on GLP-1 medications

Rare known risk (≤0.2%/year in trials). Severe steady abdominal pain that radiates to the back = ER visit. Personal pancreatitis history is a relative contraindication.

Why it happens

Mechanism would involve GLP-1 receptor signaling in pancreatic acinar cells. Post-marketing pancreatitis signal in early GLP-1 (exenatide) reporting did not survive rigorous analysis in large CVOTs.

How to manage it

  1. 1.Avoid heavy alcohol use (independent pancreatitis risk)
  2. 2.Stop GLP-1 immediately if you suspect pancreatitis
  3. 3.Tell your prescriber about any prior pancreatitis history before starting

When to call your prescriber

  • Severe steady abdominal pain that radiates to the back
  • Persistent vomiting with abdominal pain
  • Pain that worsens after eating, especially fatty meals

Affected medications

Sources

People also ask

Common questions readers ask

Does Ozempic cause hair loss?
Not directly. Hair shedding (telogen effluvium) is reported by some patients ~3 months into rapid weight loss — typical of any rapid-weight-loss state, not unique to GLP-1.
Full evidence-graded answer
What foods should you avoid on a GLP-1?
Avoid greasy, fried, and ultra-processed foods (worst nausea), high-sugar drinks (rapid reflux), and large portions of red meat or cruciferous vegetables (slow gastric emptying compounds GI side effects). Adequate protein + soluble fiber + hydration are the wins.
Full evidence-graded answer
How long do GLP-1 side effects last?
Most GI side effects (nausea, constipation, reflux) peak in weeks 1-2 after each dose increase and resolve within 4 weeks. If you stay on a stable dose without further titration, side effects typically fade for ≥80% of patients by week 12.
Full evidence-graded answer
Does Ozempic cause stomach paralysis (gastroparesis)?
GLP-1 medications delay gastric emptying as part of their mechanism — that is not stomach paralysis. True gastroparesis after GLP-1 use is rare and the absolute risk in pharmacovigilance data is small. Symptoms (severe nausea, vomiting, abdominal pain past week 8) warrant evaluation.
Full evidence-graded answer

Editorial information based on FDA-label prevalence data + AERS pharmacovigilance + patient-reported outcome corpora. Not personal medical advice.